These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26251090)

  • 1. Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.
    Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Januzzi JL; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Cohen-Solal A; Richards AM; Launay JM; Mebazaa A;
    JACC Heart Fail; 2015 Aug; 3(8):629-36. PubMed ID: 26251090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
    Bayés-Genís A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2015 Feb; 65(7):657-65. PubMed ID: 25677426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring B-type natriuretic peptide in patients undergoing therapy with neprilysin inhibitors. An emerging challenge?
    Lippi G; Sanchis-Gomar F
    Int J Cardiol; 2016 Sep; 219():111-4. PubMed ID: 27317994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of B-type natriuretic peptides in the era of angiotensin receptor-neprilysin inhibitors.
    Bettencourt P; Fonseca C; Franco F; Andrade A; Brito D
    Rev Port Cardiol; 2017 Dec; 36(12):881-884. PubMed ID: 29225105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF.
    Prausmüller S; Arfsten H; Spinka G; Freitag C; Bartko PE; Goliasch G; Strunk G; Pavo N; Hülsmann M
    J Am Heart Assoc; 2020 Jun; 9(11):e015071. PubMed ID: 32427034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.
    Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Ishihara S; Cohen Solal A; Januzzi JL; Richards AM; Launay JM; Mebazaa A;
    Eur Heart J; 2014 Dec; 35(48):3434-41. PubMed ID: 25157115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
    Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
    Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.
    Semenov AG; Katrukha AG
    Clin Chem; 2016 Apr; 62(4):617-22. PubMed ID: 26864319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
    van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL
    Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
    Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
    Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neprilysin in Heart Failure: From Oblivion to Center Stage.
    Bayés-Genís A
    JACC Heart Fail; 2015 Aug; 3(8):637-40. PubMed ID: 26251091
    [No Abstract]   [Full Text] [Related]  

  • 15. [The relevance of biomarkers in acute heart failure].
    Hellenkamp K; von Haehling S
    Internist (Berl); 2019 Jun; 60(6):587-596. PubMed ID: 31089771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure.
    Feygina EE; Artemieva MM; Postnikov AB; Tamm NN; Bloshchitsyna MN; Medvedeva NA; Katrukha AG; Semenov AG
    Clin Chem; 2019 Oct; 65(10):1239-1247. PubMed ID: 31307994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?
    Emrich IE; Vodovar N; Feuer L; Untersteller K; Nougue H; Seiler-Mussler S; Fliser D; Launay JM; Heine GH
    Nephrol Dial Transplant; 2019 Jan; 34(1):100-108. PubMed ID: 29635392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.